An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers
June Y. Hou,
Jason D. Wright,
Vuthinun Achariyapota
Affiliations
June Y. Hou
Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, USA
Jason D. Wright
Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, USA
Vuthinun Achariyapota
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand; Corresponding author at: Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, 2 Wanglang Road, Siriraj, Bangkok Noi, Bangkok 10700, Thailand.
